It is well known that pediatric hemangioma is a common disease with lesions involving the skin, within soft tissues, small arteries, small veins and capillaries, and even endangering important organs such as the brain and liver. Small strawberry nevi in infant patients can be left untreated in the early stage; observation for several years, if they do not subside, or if they affect function or beauty, appropriate treatment can be chosen. The current conventional treatment methods for pediatric hemangioma include hormone therapy, local sclerotherapy, cryotherapy, laser therapy, surgical excision and ultrasonic high-energy electric and biochemical field effect, but they are not effective for larger tumors and are prone to recurrence or sequelae. Our hospital adopts minimally invasive interventional comprehensive treatment for larger hemangioma. A catheter of only 1mm diameter is inserted through the femoral artery, and under the guidance of modern large C-arm DSA machine, the catheter is inserted into the hemangioma blood supply artery to inject sclerosing agent and embolic agent, so that the hemangioma tumor will subside under the dual effect of sclerosis and embolization. This minimally invasive interventional treatment method has the characteristics of remarkable efficacy, small trauma, quick recovery, and generally no scarring. In order to minimize the impact of large hemangiomas on normal tissues during the growth process and to leave irreparable defects later, we advocate early minimally invasive interventional treatment for rapidly growing and large hemangiomas, especially those located on the head and face. Image caption:A 45-day-old male child with a hemangioma on his right upper arm. Pre-operative, 1 month and 1 year after minimally invasive intervention.